Virtual Medicinal Product (VMP)
-
Mirabegron 25mg modified-release tablets
Name Details
Current Name
Mirabegron 25mg modified-release tablets
|
Start Date
14-02-2013
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release tablet
- Ontology Form/Route
- tabletmodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G04BD12
BNF |
Current BNF
07040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
07040200
|
Start Date
25-09-2013
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
38893411000001105 |
19-08-2020 |
|
703806003 |
01-10-2014 |
18-08-2020 |
21994911000001100 |
14-02-2013 |
30-09-2014 |
VMP Ingredients
VMP ingredients table
Mirabegron |
Based on Ingredient Substance |
|
25 mg |
|
Name
Mirabegron
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Mirabegron
-
VMP
(Current) Mirabegron 25mg modified-release tab...
Virtual Medicinal Product Pack (VMPP) Information